Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy

King Abdullah International Medical Research Center · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
chronic
myeloid leukemia, chronic, nilotinib , suboptimal response , imatinib, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 982140
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.